Triple negative aggressive phenotype controlled by miR-135b and miR-365: new theranostics candidates.
Ontology highlight
ABSTRACT: Triple negative breast cancer (TNBC) accounts for about a fifth of all breast cancers and includes a diverse group of cancers. The heterogeneity of TNBC and the lack of target receptors on the cell surface make it difficult to develop specific therapeutic treatments. These aspects cause the high negative prognosis of patients with this type of tumor. The analysis of the molecular profiles of TNBC samples has allowed a better characterization of this tumor, supporting the search for new reliable diagnostic markers. To this end, we have developed a bioinformatic approach to integrate networks of genes differentially expressed in basal breast cancer compared to healthy tissues, with miRNAs able to regulate their expression. We studied the role of these miRNAs in TNBC subtype cell lines. We th
SUBMITTER: Bertoli G
PROVIDER: S-EPMC7985188 | biostudies-literature | 2021 Mar
REPOSITORIES: biostudies-literature
ACCESS DATA